Sten Nilsson - Publications, H-index & Citations

Sten Nilsson

carl gustav carus university hospital

54H指数

420论文数

1.5W被引数

收录论文 76

发表时间

The novel cytotoxic polybisphosphonate osteodex decreases bone resorption by enhancing cell death of mature osteoclasts without affecting osteoclastogenesis of RANKL-stimulated mouse bone marrow macrophages

INVESTIGATIONAL NEW DRUGS

IF2.7

2024-03-01

OAAI

Henning, Petra; Westerlund, Anna; Moverare-Skrtic, Sofia; Lindholm, Catharina; Marquez-Mendez, Marcela; Nilsson, Sten; Holmberg, Anders R.; Lerner, Ulf H.

Cytotoxicity of poly-guanidine in medulloblastoma cell lines

INVESTIGATIONAL NEW DRUGS

IF2.7

2023-08-09

OAAI

Gallo-Oller, Gabriel; de Stahl, Teresita Diaz; Alaiya, Ayodele; Nilsson, Sten; Holmberg, Anders R.; Marquez-Mendez, Marcela

A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases

EUROPEAN JOURNAL OF CANCER

IF7.1

2023-03-01

OAAI

Thellenberg-Karlsson, Camilla; Vjaters, Egils; Kase, Marju; Tammela, Teuvo; Ojamaa, Kristiina; Norming, Ulf; Nyman, Claes; Andersson, Sven-Olof; Hublarovs, Oleg; Marquez-Holmberg, Marcela; Castellanos, Enrique; Ullen, Anders; Holmberg, Anders; Nilsson, Sten

Poly-guanidine shows high cytotoxicity in glioma cell cultures and glioma stem cells

INVESTIGATIONAL NEW DRUGS

IF2.7

2022-03-21

OAAI

Marquez, Marcela; Olausson, Karl Holmberg; Alaiya, Ayodele; Nilsson, Sten; Meurling, Lennart; Holmberg, Anders R.

Chameleon Behavior of a New Salt of 3-(Aminocarbonyl) Pyridinium Malonate and Implications for Polymorphism on the Salt/Cocrystal Continuum

CRYSTAL GROWTH & DESIGN

IF3.4

2022-02-10

OAAI

Stainton, Paul; Nauha, Elisa; Grecu, Tudor; McCabe, James F.; Munshi, Tasnim; Scowen, Ian; Chan, H. C. Stephen; Nilsson, Sten; Blagden, Nicholas

Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223 早期碱性磷酸酶动力学可作为接受镭223治疗的转移性去势抵抗性前列腺癌患者生存的生物标志物

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2021-03-08

OAAI

van der Doelen, Maarten J.; Stockhaus, Agnes; Ma, Yuanjun; Mehra, Niven; Yachnin, Jeffrey; Gerritsen, Winald R.; Nilsson, Sten; van Oort, Inge M.; Ullen, Anders

The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer

EUROPEAN UROLOGY

IF25.2

2019-03-01

OAAI

O'Sullivan, Joe M.; Heinrich, Daniel; James, Nicholas D.; Nilsson, Sten; Ost, Piet; Parker, Christopher C.; Tombal, Bertrand

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

BMC CANCER

IF3.4

2019-01-07

OAAI

Heidenreich, Axel; Gillessen, Silke; Heinrich, Daniel; Keizman, Daniel; O'Sullivan, Joe M.; Carles, Joan; Wirth, Manfred; Miller, Kurt; Reeves, John; Seger, Monica; Nilsson, Sten; Saad, Fred

Is non-mutated GPR89A protein a potential drug target in prostate cancer?

CANCER RESEARCH

IF16.6

2018-08-14

PREAI

Ma, Yuanjun; Liu, Yanling; Nilsson, Sten; Li, Chunde

Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial

EUROPEAN UROLOGY

IF25.2

2018-03-01

OAAI

Parker, Christopher C.; Coleman, Robert E.; Sartor, Oliver; Vogelzang, Nicholas J.; Bottomley, David; Heinrich, Daniel; Helle, Svein I.; O'Sullivan, Joe M.; Fossa, Sophie D.; Chodacki, Ales; Wiechno, Pawel; Logue, John; Seke, Mihalj; Widmark, Anders; Johannessen, Dag Clement; Hoskin, Peter; James, Nicholas D.; Solberg, Arne; Syndikus, Isabel; Kliment, Jan; Wedel, Steffen; Boehmer, Sibylle; Dall'Oglio, Marcos; Franzen, Lars; Bruland, Oyvind S.; Petrenciuc, Oana; Staudacher, Karin; Li, Rui; Nilsson, Sten

Current approaches to incorporation of radium-223 in clinical practice

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

2018-01-03

OAAI

Parker, Chris; Heidenreich, Axel; Nilsson, Sten; Shore, Neal

An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223

ANNALS OF ONCOLOGY

IF65.4

2017-05-01

126

OAAI

Sartor, O.; Coleman, R. E.; Nilsson, S.; Heinrich, D.; Helle, S. I.; O'Sullivan, J. M.; Vogelzang, N. J.; Bruland, O.; Kobina, S.; Wilhelm, S.; Xu, L.; Shan, M.; Kattan, M. W.; Parker, C.

RELATIONSHIP BETWEEN QUALITY OF LIFE AND OVERALL SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS IN ALSYMPCA: ANALYSIS BY PRIOR DOCETAXEL SUBGROUP

JOURNAL OF UROLOGY

IF6.8

2017-04-01

PREAI

Shore, Neal D.; Nilsson, Sten; Sartor, Oliver; Vogelzang, Nicholas J.; Coleman, Robert E.; O'Sullivan, Joe M.; Heinrich, Daniel; Bottomley, David; Hoskin, Peter; Franzen, Lars; Solberg, Arne; Reuning-Scherer, Jonathan; Zhan, Lin; Parker, Christopher

Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial

EUROPEAN JOURNAL OF CANCER

IF7.1

2017-01-01

OAAI

Parker, Christopher; Zhan, Lin; Cislo, Paul; Reuning-Scherer, Jonathan; Vogelzang, Nicholas J.; Nilsson, Sten; Sartor, Oliver; O'Sullivan, Joe M.; Coleman, Robert E.

Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial

EUROPEAN UROLOGY

IF25.2

2016-11-01

OAAI

Parker, Christopher; Finkelstein, Steven E.; Michalski, Jeff M.; O'Sullivan, Joe M.; Bruland, Oyvind; Vogelzang, Nicholas J.; Coleman, Robert E.; Nilsson, Sten; Sartor, Oliver; Li, Rui; Seger, Monica A.; Bottomley, David

Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)

ANNALS OF ONCOLOGY

IF65.4

2016-10-01

OAAI

Saad, F.; Heidenreich, A.; Heinrich, D.; Keizman, D.; O'Sullivan, J. M.; Carles, J.; Wirth, M.; Miller, K.; Gratt, J.; Seger-Van Tol, M.; Nilsson, S.; Gillessen, S.

Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)

ANNALS OF ONCOLOGY

IF65.4

2016-10-01

OAAI

Heinrich, D.; Gillessen, S.; Heidenreich, A.; Keizman, D.; O'Sullivan, J. M.; Carles, J.; Wirth, M.; Miller, K.; Procopio, G.; Gratt, J.; Seger-Van Tol, M.; Nilsson, S.; Saad, F.

Analysis of overall survival by number of radium-223 injections received in an international expanded access program (iEAP)

ANNALS OF ONCOLOGY

IF65.4

2016-09-01

OAAI

Paganelli, G.; Procopio, G.; Cabria, M.; Cortesi, E.; Tucci, M.; Farnesi, A.; Mango, L.; Baldari, S.; Hamzaj, A.; Caffo, O.; Marchetti, P.; Dalla Pozza, F.; Zucali, P. A.; Saad, F.; Nilsson, S.; Heinrich, D.

Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life differences: A randomised prospective 18-month follow-up study

EUROPEAN JOURNAL OF CANCER

IF7.1

2016-09-01

PREAI

Majumder, Khairul; Nilsson, Sten; Johansson, Hemming; Ullen, Anders; Lennernas, Bo; Bergenmar, Mia; Brandberg, Yvonne

Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study

ANNALS OF ONCOLOGY

IF65.4

2016-05-01

132

OAAI

Nilsson, S.; Cislo, P.; Sartor, O.; Vogelzang, N. J.; Coleman, R. E.; O'Sullivan, J. M.; Reuning-Scherer, J.; Shan, M.; Zhan, L.; Parker, C.

研究方向